No consensus has been reached on how to define cerebrospinal fluid HIV-1 escape (CSF-E). We describe its prevalence in 1095 paired CSF-plasma HIV-RNA measurements from antiretroviral-treated patients according to several definitions and neurological affections. CSF-E prevalence varied substantially (9.0-38.9%) and was higher in patients with cerebrovascular disorders, HIV-associated dementia and white matter abnormalities. Considering the variability in HIV-RNA quantification assays, the biological relevance of viral escape at different thresholds needs to be accurately assessed.

Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities. Is it time to assess the definitions? / Trunfio, Mattia; Pinnetti, Carmela; Focà, Emanuele; Bai, Francesca; Maffongelli, Gaetano; Celani, Luigi; Cinque, Paola; Celotti, Anna; Andreoni, Massimo; D'Arminio Monforte, Antonella; D'Ettorre, Gabriella; Antinori, Andrea; Calcagno, Andrea. - In: AIDS. - ISSN 1473-5571. - 33:4(2019), pp. 759-762. [10.1097/QAD.0000000000002091]

Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities. Is it time to assess the definitions?

Maffongelli, Gaetano;Celani, Luigi;Andreoni, Massimo;D'Arminio Monforte, Antonella;D'Ettorre, Gabriella;
2019

Abstract

No consensus has been reached on how to define cerebrospinal fluid HIV-1 escape (CSF-E). We describe its prevalence in 1095 paired CSF-plasma HIV-RNA measurements from antiretroviral-treated patients according to several definitions and neurological affections. CSF-E prevalence varied substantially (9.0-38.9%) and was higher in patients with cerebrovascular disorders, HIV-associated dementia and white matter abnormalities. Considering the variability in HIV-RNA quantification assays, the biological relevance of viral escape at different thresholds needs to be accurately assessed.
2019
immunology and allergy; immunology; infectious diseases
01 Pubblicazione su rivista::01f Lettera, Nota
Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities. Is it time to assess the definitions? / Trunfio, Mattia; Pinnetti, Carmela; Focà, Emanuele; Bai, Francesca; Maffongelli, Gaetano; Celani, Luigi; Cinque, Paola; Celotti, Anna; Andreoni, Massimo; D'Arminio Monforte, Antonella; D'Ettorre, Gabriella; Antinori, Andrea; Calcagno, Andrea. - In: AIDS. - ISSN 1473-5571. - 33:4(2019), pp. 759-762. [10.1097/QAD.0000000000002091]
File allegati a questo prodotto
File Dimensione Formato  
Trunfio_Cerebrospinal_2019.pdf

accesso aperto

Tipologia: Documento in Pre-print (manoscritto inviato all'editore, precedente alla peer review)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 216.88 kB
Formato Adobe PDF
216.88 kB Adobe PDF
Trunfio_Cerebrospinal-fluid_2019.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 119.81 kB
Formato Adobe PDF
119.81 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1268760
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 15
social impact